1The Zerigo Health Solution may be provided as a value-added benefit to your pharmacy or employer health plan. A copay or co-insurance may be required when you see a physician to request a prescription for phototherapy treatment.
2The Zerigo Solution received FDA clearance on May 23, 2017. The Zerigo Health Phototherapy System is an Ultraviolet Light Emitting Medical Device. It is intended for use in localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis and leukoderma on all skin types (I-VI). The Zerigo Health Solution is not intended to provide medical advice or be a substitution for appropriate or necessary health care treatment.
3Joint American Academy of Dermatology: National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy.